123 related articles for article (PubMed ID: 30350857)
1. Risk factors for preterm delivery among early onset cancer survivors: A Finnish register-based study.
Melin J; Heinävaara S; Malila N; Tiitinen A; Gissler M; Madanat-Harjuoja L
Int J Cancer; 2019 Apr; 144(8):1954-1961. PubMed ID: 30350857
[TBL] [Abstract][Full Text] [Related]
2. Maternal obesity and risk of preterm delivery.
Cnattingius S; Villamor E; Johansson S; Edstedt Bonamy AK; Persson M; Wikström AK; Granath F
JAMA; 2013 Jun; 309(22):2362-70. PubMed ID: 23757084
[TBL] [Abstract][Full Text] [Related]
3. Modifiable and non-modifiable risk factors for preterm delivery among adolescent and young adult cancer survivors.
Anderson C; Smitherman AB; Engel SM; Nichols HB
Cancer Causes Control; 2018 Feb; 29(2):289-295. PubMed ID: 29196836
[TBL] [Abstract][Full Text] [Related]
4. Preterm delivery among female survivors of childhood, adolescent and young adulthood cancer.
Madanat-Harjuoja LM; Malila N; Lähteenmäki PM; Boice JD; Gissler M; Dyba T
Int J Cancer; 2010 Oct; 127(7):1669-79. PubMed ID: 20054856
[TBL] [Abstract][Full Text] [Related]
5. Maternal complications in twin pregnancies in Finland during 1987-2014: a retrospective study.
Rissanen AS; Jernman RM; Gissler M; Nupponen I; Nuutila ME
BMC Pregnancy Childbirth; 2019 Sep; 19(1):337. PubMed ID: 31533649
[TBL] [Abstract][Full Text] [Related]
6. Fertility treatments among female cancer survivors giving birth - a Finnish register-based study.
Melin J; Madanat-Harjuoja L; Heinävaara S; Malila N; Gissler M; Tiitinen A
Acta Oncol; 2017 Aug; 56(8):1089-1093. PubMed ID: 28339338
[TBL] [Abstract][Full Text] [Related]
7. Use of fertility drugs in early-onset female cancer survivors-A Finnish register-based study on 8,929 survivors.
Melin J; Madanat-Harjuoja L; Hirvonen E; Seppä K; Malila N; Pitkäniemi J; Gissler M; Tiitinen A
Int J Cancer; 2020 Feb; 146(3):829-838. PubMed ID: 30989639
[TBL] [Abstract][Full Text] [Related]
8. Smoking among older childbearing women - a marker of risky health behaviour a registry-based study in Finland.
Lamminpää R; Vehviläinen-Julkunen K; Gissler M; Heinonen S
BMC Public Health; 2013 Dec; 13():1179. PubMed ID: 24330715
[TBL] [Abstract][Full Text] [Related]
9. Reasons for cesarean and medically indicated deliveries in pregnancies in women with systemic lupus erythematosus.
Eudy AM; Jayasundara M; Haroun T; Neil L; James AH; Clowse MEB
Lupus; 2018 Mar; 27(3):351-356. PubMed ID: 28699378
[TBL] [Abstract][Full Text] [Related]
10. [Risk factors for low birth weight and intrauterine growth retardation in Santiago, Chile].
Vega J; Sáez G; Smith M; Agurto M; Morris NM
Rev Med Chil; 1993 Oct; 121(10):1210-9. PubMed ID: 8191127
[TBL] [Abstract][Full Text] [Related]
11. The risk of preterm birth and growth restriction in pregnancy after cancer.
Hartnett KP; Ward KC; Kramer MR; Lash TL; Mertens AC; Spencer JB; Fothergill A; Howards PP
Int J Cancer; 2017 Dec; 141(11):2187-2196. PubMed ID: 28836277
[TBL] [Abstract][Full Text] [Related]
12. Adverse Obstetric Outcomes Among Early-Onset Cancer Survivors in Finland.
Melin J; Heinävaara S; Malila N; Tiitinen A; Gissler M; Madanat-Harjuoja L
Obstet Gynecol; 2015 Oct; 126(4):803-810. PubMed ID: 26348187
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy Achieved Using Donor Eggs in Cancer Survivors with Treatment-Induced Ovarian Failure: Obstetric and Perinatal Outcome.
Marklund A; Nasiell J; Berger AS; Fagerberg A; Rodriguez-Wallberg KA
J Womens Health (Larchmt); 2018 Jul; 27(7):939-945. PubMed ID: 29715049
[TBL] [Abstract][Full Text] [Related]
14. Diseases of renal function and bone metabolism after treatment for early onset cancer: A registry-based study.
Liuhto N; Grönroos MH; Malila N; Madanat-Harjuoja L; Matomäki J; Lähteenmäki P
Int J Cancer; 2020 Mar; 146(5):1324-1332. PubMed ID: 31523804
[TBL] [Abstract][Full Text] [Related]
15. Singleton pregnancies after in vitro fertilization in Estonia: a register-based study of complications and adverse outcomes in relation to the maternal socio-demographic background.
Rahu K; Allvee K; Karro H; Rahu M
BMC Pregnancy Childbirth; 2019 Jan; 19(1):51. PubMed ID: 30696425
[TBL] [Abstract][Full Text] [Related]
16. Maternal age and adverse pregnancy outcome: a cohort study.
Khalil A; Syngelaki A; Maiz N; Zinevich Y; Nicolaides KH
Ultrasound Obstet Gynecol; 2013 Dec; 42(6):634-43. PubMed ID: 23630102
[TBL] [Abstract][Full Text] [Related]
17. Placental abruption and subsequent risk of pre-eclampsia: a population-based case-control study.
Parker SE; Werler MM; Gissler M; Tikkanen M; Ananth CV
Paediatr Perinat Epidemiol; 2015 May; 29(3):211-9. PubMed ID: 25761509
[TBL] [Abstract][Full Text] [Related]
18. Preterm birth, neonatal therapies and the risk of childhood cancer.
Seppälä LK; Vettenranta K; Leinonen MK; Tommiska V; Madanat-Harjuoja LM
Int J Cancer; 2021 May; 148(9):2139-2147. PubMed ID: 33128776
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and risk factors related to preterm birth in Brazil.
Leal MD; Esteves-Pereira AP; Nakamura-Pereira M; Torres JA; Theme-Filha M; Domingues RM; Dias MA; Moreira ME; Gama SG
Reprod Health; 2016 Oct; 13(Suppl 3):127. PubMed ID: 27766978
[TBL] [Abstract][Full Text] [Related]
20. Increased risk of preterm delivery and pre-eclampsia in women with polycystic ovary syndrome and hyperandrogenaemia.
Naver KV; Grinsted J; Larsen SO; Hedley PL; Jørgensen FS; Christiansen M; Nilas L
BJOG; 2014 Apr; 121(5):575-81. PubMed ID: 24418062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
